查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2017588

医疗保健领域人工智慧市场：按类型、交付管道、疾病类别、应用、部署模式和最终用户划分——2026-2030年全球市场预测

Artificial Intelligence in Healthcare Market by Type, Delivery Channel, Disease Category, Application, Deployment Mode, End-User - Global Forecast 2026-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年医疗领域的人工智慧 (AI) 市场价值为 145.5 亿美元，预计到 2025 年将成长至 170.1 亿美元，复合年增长率为 18.13%，到 2030 年将达到 395.6 亿美元。

主要市场统计数据
基准年 2024 145.5亿美元
预计年份：2025年 170.1亿美元
预测年份 2030 395.6亿美元
复合年增长率 (%) 18.13%

简要概述人工智慧如何改变临床护理、工作流程和研究过程，同时仍需要管治和临床医生的信任。

人工智慧正迅速改变医疗保健的提供、研究和管理方式，它能够实现更精准的诊断、更有效率的工作流程，并开闢新的治疗方法途径。在临床实践中，人工智慧驱动的工具透过影像模式识别、基因组分析和即时病患监测，为临床医生提供决策支援。同时，人工智慧也正在利用商业应用优化行政工作流程，简化计费和预约管理，并透过快速资讯搜寻和持续护理缩短治疗时间。先进演算法与丰富的临床资料集的整合，使各机构能够从概念验证（PoC）试点阶段过渡到影响跨学科诊疗路径的整合解决方案。

演算法精度、边缘监测、影像分析和云端基础设施的进步如何改变临床实践和商业性伙伴关係。

在演算法能力、资料可用性和云端原生基础设施的推动下，医疗保健领域正经历着一场变革。边缘运算和穿戴式装置使得在传统医疗环境之外也能病患监测成为可能，从而产生适用于近即时分析的高速感测器和生命体征数据。同时，影像分析和电脑视觉技术的进步正在提昇放射学和病理学的诊断能力，实现疾病表型的早期检测和更精准的表征。此外，人工智慧驱动的药物发现平台和基因组分析正在缩短研发週期，并使标靶治疗的开发更加数据驱动和灵活。

评估关税和贸易政策的波动如何对医疗保健人工智慧生态系统内的供应链带来压力，如何影响部署选择，以及如何促进製造业的韧性。

近期关税趋势和贸易政策的变化为人工智慧医疗技术的供应链规划和供应商策略带来了新的变数。影响硬体组件（例如监控设备、机器人和穿戴式设备组件）的关税可能导致医疗服务提供者和原始设备製造商 (OEM) 的成本增加和采购週期延长。这些变化凸显了本地化生产、供应商网路多元化和策略性库存规划的重要性，以确保关键设备的持续供应。同时，影响资料中心硬体和网路元件的关税正在影响私有云端部署和边缘运算解决方案的经济效益，促使各组织重新评估其在公共云端、私有云端、混合云和本地部署架构中的部署模式。

透过进行全面的细分，明确类型、交付管道、资料类别、临床应用、部署模型和最终用户，我们可以製定有针对性的部署策略。

精细化的细分框架对于理解人工智慧在医疗保健领域的机会和应用路径至关重要。根据类型，所提供的服务可分为硬体、服务和软体。硬体包括监测设备、机器人和穿戴式设备，这些设备旨在收集临床讯号或辅助完成手术操作。服务包括咨询服务、实施和整合服务以及维护和支援服务，这些服务能够确保成功实施和生命週期管理。软体包括临床决策支援系统、资料管理和分析工具、药物研发平台、医学影像平台以及自然语言处理应用程序，这些应用程式能够从各种资料来源中提取临床资讯。

美洲、欧洲、中东和非洲以及亚太地区的趋势和政策环境如何影响医疗保健领域的人工智慧采用、检验和商业化策略。

区域趋势塑造了人工智慧在医疗保健领域的应用路径和监管预期，美洲、欧洲、中东和非洲以及亚太地区的驱动力各不相同。在美洲，集中化的医疗服务网络和成熟的支付体系创造了有利于临床检验和报销的良好环境，从而加速了企业级应用。同时，充满活力的Start-Ups生态系统和领先的研究机构正在推动药物研发和影像分析领域的创新。跨境合作以及与云端供应商的伙伴关係经常被用于支持可扩展性和转化研究计画。

主要企业如何将临床检验、互通性、策略伙伴关係和服务主导模式结合，以实现服务差异化并扩大其服务的应用？

该领域的主要企业正朝着差异化策略靠拢，这些策略融合了技术深度、临床专长和监管洞察力。他们正投资于平台互通性，以实现与电子健康记录系统和影像檔案库的集成，同时建立针对肿瘤学、心臟病学和神经病学等领域的特定模型，以加速临床应用。与大学附属医院和研究机构建立策略伙伴关係十分普遍，这为他们提供了获取精选数据集、临床检验队列和真实世界数据所需的资源，从而支持监管申报和与保险公司的咨询。同时，与云端服务供应商和系统整合商的合作也帮助供应商扩展部署规模，并确保强大的资料安全性和合规性。

医疗保健领导者采取切实可行的步骤，以协调资料管治、临床检验、供应链弹性和人才准备，从而采用人工智慧。

产业领导者应制定切实可行、以证据为基础的蓝图，使技术投资与临床优先事项和营运限制保持一致。首先，应优先考虑资料管治和互通性工作，以确保高品质、具代表性的资料集，并与电子健康记录和影像系统无缝整合。其次，应设计切实可行、可重复且全面的临床检验研究，以期最终实现实际的临床应用，而非仅关注孤立的表现指标。在采购和供应链规划方面，应实现供应商多元化，评估关键硬体组件的近岸外包方案，并评估关税对医疗设备供应和整体拥有成本的影响。

采用严谨的混合方法研究途径，结合一手访谈、二手文献、检验、细分映射和专家检验。

本报告整合了结构化、系统化的研究方法所得出的洞见，该方法结合了初步和二次调查、专家咨询以及反覆检验。初步研究包括对临床负责人、技术主管和供应链经理的深入访谈，以了解部署的实际情况和策略重点。二次研究包括同侪审查文献、监管指导文件、技术白皮书和供应商产品资料，以阐明技术能力和证据标准。资料三角测量技术用于协调不同观点，并识别不同资讯来源的通用主题。

将人工智慧创新负责任地转化为永续的临床和营运影响，需要整合证据、互通性并加强跨部门合作。

人工智慧既代表着医疗保健产业的技术飞跃，也带来了巨大的组织挑战。其最具前景的应用在于显着改善临床决策、简化行政流程并加强病患监测，同时也要遵守监管和伦理框架。成功实施取决于可靠的临床证据、与临床医生工作流程的无缝整合、稳健的供应链以及前瞻性的商业化策略。区域监管差异和贸易政策趋势增加了复杂性，但也为在地化和策略伙伴关係创造了机会。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：医疗领域的人工智慧市场：按类型划分

  • 硬体
    • 监控设备
    • 机器人技术
    • 穿戴式装置
  • 服务
    • 咨询服务
    • 实施和整合服务
    • 维护和支援
  • 软体
    • 临床决策支援系统
    • 数据管理与分析
    • 药物发现平台
    • 医学影像诊断平台
    • 自然语言处理应用

第九章：按交付管道分類的医疗领域人工智慧市场

  • 数位平台
  • 现场服务
  • 远端服务

第十章：按疾病分類的医疗领域人工智慧市场

  • 心血管疾病
  • 皮肤病
  • 消化系统疾病
  • 神经系统疾病
  • 肿瘤疾病
  • 整形外科疾病
  • 呼吸系统疾病

第十一章：医疗领域的人工智慧市场：按应用领域划分

  • 管理工作流程
    • 预约管理
    • 帐单管理
    • 合规管理
    • 记录管理
  • 诊断
    • 临床试验
    • 基因检测
    • 病理诊断
    • 放射诊断
  • 病患监测
    • 重症加护病房监测
    • 远端患者监护
    • 生命征象监测
  • 治疗管理
    • 药物治疗优化
    • 个人化医疗
    • 放射治疗
    • 机器人手术

第十二章：医疗领域的人工智慧市场：依部署模式划分

  • 基于云端的
  • 杂交种
  • 现场

第十三章：医疗领域的人工智慧市场：依最终用户划分

  • 学术和研究机构
  • 诊断中心
  • 医院和医疗保健机构
  • 製药和生物技术公司

第十四章：医疗领域的人工智慧市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：医疗领域的人工智慧市场：按类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：医疗领域的人工智慧市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国医疗保健产业的人工智慧市场

第十八章：中国医疗保健产业的人工智慧市场

第十九章 竞争情势

  • 2024年市场集中度分析
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2024 年
  • 2024年产品系列分析
  • 基准分析，2024 年
  • Amazon Web Services, Inc.
  • GE Healthcare
  • Google, LLC by Alphabet, Inc.
  • International Business Machines Corporation
  • IQVIA Holdings Inc.
  • Koninklijke Philips NV
  • Microsoft Corporation
  • Nano-X Imaging Ltd.
  • Oracle Corporation
  • Salesforce, Inc.
  • Siemens Healthineers AG
Product Code: MRR-031BF22F9550

The Artificial Intelligence in Healthcare Market was valued at USD 14.55 billion in 2024 and is projected to grow to USD 17.01 billion in 2025, with a CAGR of 18.13%, reaching USD 39.56 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 14.55 billion
Estimated Year [2025] USD 17.01 billion
Forecast Year [2030] USD 39.56 billion
CAGR (%) 18.13%

A concise framing of how artificial intelligence is transforming clinical care, operational workflows, and research pathways while requiring governance and clinician trust

Artificial intelligence is rapidly reshaping the contours of healthcare delivery, research, and administration by enabling higher-precision diagnostics, more efficient workflows, and novel pathways for therapeutic discovery. In clinical settings, AI-driven tools are augmenting clinician decision-making through pattern recognition in imaging, genomic interpretation, and real-time patient monitoring. Concurrently, operational applications leverage AI to optimize administrative workflow, streamline billing and appointment scheduling, and reduce time-to-treatment by enabling faster information retrieval and continuity of care. The convergence of advanced algorithms with richer clinical data sets has allowed organizations to move from proof-of-concept pilots to integrated solutions that can influence care pathways across specialties.

However, translating AI potential into routine practice requires managing complex intersections of data governance, interoperability, and clinical validation. Effective adoption hinges not only on technological robustness but also on clinician trust, regulatory alignment, and demonstrable improvements in patient outcomes. Given the diversity of AI modalities-from clinical decision support systems to natural language processing and robotic surgery-stakeholders must evaluate solutions against clinical readiness, workforce implications, and ethical considerations. In this context, healthcare leaders must balance rapid innovation with stringent evaluative frameworks to ensure patient safety, equitable deployment, and sustainable integration within existing care ecosystems.

How advancements in algorithmic precision, edge monitoring, imaging analytics, and cloud infrastructure are reshaping clinical practice and commercial partnerships

The landscape of healthcare is undergoing transformative shifts driven by advances in algorithmic capability, data availability, and cloud-native infrastructure. Edge and wearable devices are enabling continuous patient monitoring outside traditional settings, which in turn generates high-velocity sensor and vital sign data suitable for near-real-time analytics. Simultaneously, improvements in imaging analytics and computer vision have elevated diagnostic performance for radiology and pathology, enabling earlier detection and more precise characterization of disease phenotypes. At the same time, AI-assisted drug discovery platforms and genomic analytics are compressing research timelines and making targeted therapy development more data-driven and adaptive.

These technological shifts are accompanied by systemic changes in delivery and commercialization. Health systems are increasingly partnering with software and services providers to accelerate integration, while payers show growing interest in reimbursement models that reward outcomes tied to validated AI tools. Interoperability initiatives and standards for clinical data exchange are gaining traction, lowering the friction for multi-source data synthesis. As a result, the competitive landscape is expanding beyond traditional medtech and software vendors to include cloud providers, specialty analytics firms, and clinical labs, each bringing distinct capabilities. Going forward, the most impactful innovations will be those that combine robust clinical validation with seamless workflow integration and clear value propositions for clinicians and patients.

Assessment of how evolving tariffs and trade policy create supply chain pressures, influence deployment choices, and incentivize manufacturing resilience in healthcare AI ecosystems

Recent tariff movements and changes in trade policy have introduced new variables into supply chain planning and vendor strategy for AI-enabled healthcare technologies. Tariffs that affect hardware components, such as monitoring equipment, robotics, and wearable device assemblies, can increase costs and elongate procurement cycles for providers and OEMs alike. These shifts place a premium on localized manufacturing, diversified supplier networks, and strategic inventory planning to maintain continuity of critical device availability. In parallel, tariffs that influence data center hardware and networking components can impact the economics of private cloud deployments and edge compute solutions, prompting organizations to reassess deployment modes between public cloud, private cloud, hybrid, and on-premise architectures.

Moreover, procurement teams are increasingly weighing the implications of trade policy on vendor selection, favoring partners with resilient supply chains and multi-region manufacturing footprints. Legal and compliance functions must also account for evolving import-export controls, especially where specialized components for medical imaging platforms or robotic surgery systems are sourced across jurisdictions. Consequently, healthcare organizations and technology vendors are recalibrating strategic sourcing, exploring nearshoring or onshoring options, and incorporating tariff sensitivity analyses into contractual negotiations, with the goal of minimizing operational disruption while preserving access to critical AI-enabled capabilities.

Comprehensive segmentation that delineates types, delivery channels, data categories, clinical applications, deployment modes, and end users to inform targeted adoption strategies

A nuanced segmentation framework is essential for understanding opportunities and implementation pathways across AI in healthcare. Based on Type, offerings can be categorized across Hardware, Services, and Software; hardware comprises monitoring equipment, robotics, and wearable devices designed to capture clinical signals or assist procedural tasks; services cover consulting services, deployment and integration services, and maintenance and support that enable successful implementation and lifecycle management; and software spans clinical decision support systems, data management and analysis tools, drug discovery platforms, medical imaging platforms, and natural language processing applications that extract clinical intelligence from diverse data sources.

Based on Delivery Channel, solutions are delivered through digital platforms, mobile applications, onsite services, remote services, and wearable devices, with mobile applications further segmented by operating environment into Android applications and iOS applications that determine integration and user experience considerations. Based on Organization Scale, adoption dynamics differ between large enterprises and small and medium enterprises, with larger systems often prioritizing integration at scale and SMEs emphasizing turnkey, lower-friction deployments. Based on Data Category, analytic approaches must accommodate genomic data, imaging data, semi-structured data, sensor data, structured data, and unstructured data; genomic data includes exome sequencing and whole genome sequencing datasets, while imaging data includes CT, MRI, and X-ray modalities that require specialized preprocessing and annotation workflows.

Based on Disease Category, AI applications address cardiovascular disorders, dermatological disorders, gastrointestinal disorders, neurological disorders, oncology disorders, orthopedic disorders, and respiratory disorders, each presenting unique diagnostic and therapeutic data patterns. Based on Application Area, implementations span administrative workflow, diagnostics, patient monitoring, and treatment management; administrative workflow includes appointment scheduling, billing management, compliance management, and record management, whereas diagnostics comprises clinical testing, genetic testing, pathology diagnostics, and radiology diagnostics; patient monitoring encompasses ICU monitoring, inpatient monitoring, remote patient monitoring, and vital sign monitoring; and treatment management covers drug therapy optimization, personalized medicine, radiation therapy, and robotic surgery. Based on Deployment Mode, environments are cloud-based, hybrid, and on-premise, with cloud-based options further differentiated into private cloud and public cloud to meet security and latency requirements. Finally, based on End User Type, primary adopters include diagnostic centers, hospitals, pharmaceutical companies, and research institutes, each of which demands distinct service levels, validation evidence, and regulatory documentation.

Regional dynamics and policy environments across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence adoption, validation, and commercialization strategies

Regional dynamics shape adoption pathways and regulatory expectations for AI in healthcare, with distinct drivers across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, concentrated healthcare delivery networks and established payer systems create an environment where clinical validation and reimbursement pathways can accelerate enterprise-scale deployments, while vibrant startup ecosystems and advanced research institutions drive innovation in drug discovery and imaging analytics. Cross-border collaborations and partnerships with cloud vendors are frequently leveraged to support scalability and translational research programs.

In Europe, Middle East & Africa, regulatory harmonization across certain jurisdictions and growing investment in digital health infrastructure influence deployment strategies, with an emphasis on privacy, data protection, and interoperability. Policymakers and health systems in these regions often prioritize robust governance frameworks and ethical AI use, prompting vendors to demonstrate compliance and explainability. Meanwhile, the Asia-Pacific region exhibits rapid adoption of mobile and remote monitoring solutions driven by large populations, heterogeneous care access, and strong public-private investment in health IT. Local manufacturing capacities, regulatory pathways, and regional partnerships are crucial considerations for vendors seeking to establish or expand footprints. Across regions, successful strategies balance compliance, clinical validation, and culturally appropriate patient engagement to ensure sustainable adoption and equitable benefits.

How leading firms combine clinical validation, interoperability, strategic partnerships, and service-led models to differentiate offerings and scale adoption

Leading organizations in this space are converging around differentiated strategies that combine technological depth with clinical domain expertise and regulatory acumen. Companies are investing in platform interoperability to enable integration with electronic health record systems and imaging archives, while concurrently building domain-specific models for oncology, cardiology, and neurology to accelerate clinical adoption. Strategic partnerships with academic medical centers and research institutes are common, enabling access to curated datasets, clinical validation cohorts, and real-world evidence necessary to support regulatory submissions and payer discussions. In parallel, alliances with cloud providers and systems integrators help vendors scale deployments and ensure robust data security and compliance.

Commercial strategies increasingly emphasize outcome-oriented value propositions, wherein vendors demonstrate how AI tools improve clinical workflows, reduce diagnostic variability, or enhance patient monitoring without adding clinician burden. Service models augment software and hardware offerings with consulting, deployment, and maintenance services to reduce implementation friction. Additionally, many companies are expanding their geographic footprint through localized partnerships and manufacturing arrangements to mitigate supply chain risks and comply with regional procurement requirements. Collectively, these strategic moves reflect a maturing competitive landscape in which differentiation is built on clinical validation, integration capabilities, and the ability to support complex enterprise requirements.

Actionable steps for healthcare leaders to align data governance, clinical validation, supply chain resilience, and workforce readiness for AI adoption

Industry leaders should adopt a pragmatic, evidence-driven roadmap that aligns technological investment with clinical priorities and operational constraints. First, prioritize data governance and interoperability initiatives to ensure high-quality, representative datasets and seamless integration with electronic health records and imaging systems. Next, design clinical validation studies that are pragmatic, reproducible, and embedded in care pathways so that results translate into actionable clinical adoption rather than isolated performance metrics. In procurement and supply chain planning, diversify sourcing and evaluate nearshoring options for critical hardware components while assessing the tariff sensitivities that could affect device availability and total cost of ownership.

Additionally, invest in workforce development and clinician engagement programs to build trust and fluency in AI-driven workflows; co-design interfaces with end users and pilot incrementally to gather feedback and iterate rapidly. From a security and compliance perspective, implement robust privacy preservation, auditing, and explainability features to meet regulatory expectations and support payer discussions. Consider hybrid deployment models to balance latency, control, and scalability while leveraging cloud partnerships for advanced analytics and model lifecycle management. Finally, pursue outcome-based contracts and evidence generation that demonstrate clinical and operational value, and maintain flexible commercial terms that accommodate organizational heterogeneity and evolving regulatory requirements.

A rigorous mixed-methods research approach integrating primary interviews, secondary literature, triangulation, segmentation mapping, and expert validation

This report synthesizes insights derived from a structured, methodical research approach combining primary and secondary sources, expert consultations, and iterative validation. Primary research included in-depth interviews with clinical leaders, technology executives, and supply chain managers to capture implementation realities and strategic priorities. Secondary research encompassed peer-reviewed literature, regulatory guidance documents, technical white papers, and vendor product literature to contextualize technological capabilities and evidence standards. Data triangulation techniques were used to reconcile differing perspectives and to identify consistent themes across sources.

Segmentation mapping was applied to classify technologies, delivery channels, data types, application areas, deployment modes, and end users, ensuring that analytic narratives remain aligned with real-world adoption scenarios. Qualitative analysis highlighted workflow integration challenges, clinician acceptance factors, and regulatory considerations, while thematic synthesis distilled recurring patterns around validation, interoperability, and commercialization. Validation rounds with independent subject-matter experts and clinicians refined the findings and ensured practical relevance. Constraints and limitations, including variations in regional regulatory regimes and heterogeneity in data quality, are acknowledged and factored into the interpretation of insights. Ethical considerations and data privacy protections informed the research design, and participant confidentiality was maintained throughout the study.

Synthesis of how evidence, interoperability, and cross-sector collaboration are essential to responsibly translate AI innovations into sustained clinical and operational impact

Artificial intelligence represents both a technological leap and an organizational challenge for healthcare. The most promising applications are those that demonstrably improve clinical decision-making, streamline administrative workflows, and enhance patient monitoring while aligning with regulatory and ethical frameworks. Adoption success depends on a combination of robust clinical evidence, seamless integration into clinician workflows, resilient supply chains, and forward-looking commercialization strategies. Regional regulatory differences and trade policy dynamics add layers of complexity but also create opportunities for localization and strategic partnerships.

As the ecosystem matures, stakeholders who focus on interoperable architectures, transparent validation practices, and patient-centric design will be best positioned to translate AI capabilities into measurable improvements in care delivery. Ultimately, the transition from pilot projects to sustained deployment requires sustained investment in data governance, clinician training, and outcome-oriented evidence generation. By following a disciplined, evidence-based approach and cultivating cross-sector collaborations, organizations can responsibly harness AI to deliver safer, more efficient, and more equitable healthcare.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2024
  • 3.5. FPNV Positioning Matrix, 2024
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Healthcare Market, by Type

  • 8.1. Hardware
    • 8.1.1. Monitoring Equipment
    • 8.1.2. Robotics
    • 8.1.3. Wearable Devices
  • 8.2. Services
    • 8.2.1. Consulting Services
    • 8.2.2. Deployment & Integration Services
    • 8.2.3. Maintenance & Support
  • 8.3. Software
    • 8.3.1. Clinical Decision Support Systems
    • 8.3.2. Data Management & Analysis
    • 8.3.3. Drug Discovery Platforms
    • 8.3.4. Medical Imaging Platforms
    • 8.3.5. Natural Language Processing Applications

9. Artificial Intelligence in Healthcare Market, by Delivery Channel

  • 9.1. Digital Platforms
  • 9.2. Onsite Services
  • 9.3. Remote Services

10. Artificial Intelligence in Healthcare Market, by Disease Category

  • 10.1. Cardiovascular Disorders
  • 10.2. Dermatological Disorders
  • 10.3. Gastrointestinal Disorders
  • 10.4. Neurological Disorders
  • 10.5. Oncology Disorders
  • 10.6. Orthopedic Disorders
  • 10.7. Respiratory Disorders

11. Artificial Intelligence in Healthcare Market, by Application

  • 11.1. Administrative Workflow
    • 11.1.1. Appointment Scheduling
    • 11.1.2. Billing Management
    • 11.1.3. Compliance Management
    • 11.1.4. Record Management
  • 11.2. Diagnostics
    • 11.2.1. Clinical Testing
    • 11.2.2. Genetic Testing
    • 11.2.3. Pathology Diagnostics
    • 11.2.4. Radiology Diagnostics
  • 11.3. Patient Monitoring
    • 11.3.1. ICU Monitoring
    • 11.3.2. Remote Patient Monitoring
    • 11.3.3. Vital Sign Monitoring
  • 11.4. Treatment Management
    • 11.4.1. Drug Therapy Optimization
    • 11.4.2. Personalized Medicine
    • 11.4.3. Radiation Therapy
    • 11.4.4. Robotic Surgery

12. Artificial Intelligence in Healthcare Market, by Deployment Mode

  • 12.1. Cloud-Based
  • 12.2. Hybrid
  • 12.3. On-Premise

13. Artificial Intelligence in Healthcare Market, by End-User

  • 13.1. Academic & Research Institutions
  • 13.2. Diagnostic Centers
  • 13.3. Hospitals & Healthcare Providers
  • 13.4. Pharmaceutical & Biotechnology Companies

14. Artificial Intelligence in Healthcare Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Artificial Intelligence in Healthcare Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Artificial Intelligence in Healthcare Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Artificial Intelligence in Healthcare Market

18. China Artificial Intelligence in Healthcare Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2024
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2024
  • 19.3. Product Portfolio Analysis, 2024
  • 19.4. Benchmarking Analysis, 2024
  • 19.5. Amazon Web Services, Inc.
  • 19.6. GE Healthcare
  • 19.7. Google, LLC by Alphabet, Inc.
  • 19.8. International Business Machines Corporation
  • 19.9. IQVIA Holdings Inc.
  • 19.10. Koninklijke Philips N.V.
  • 19.11. Microsoft Corporation
  • 19.12. Nano-X Imaging Ltd.
  • 19.13. Oracle Corporation
  • 19.14. Salesforce, Inc.
  • 19.15. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 14. CHINA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MONITORING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MONITORING EQUIPMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MONITORING EQUIPMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT & INTEGRATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT & INTEGRATION SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT & INTEGRATION SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY PLATFORMS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG DISCOVERY PLATFORMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING PLATFORMS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY MEDICAL IMAGING PLATFORMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING APPLICATIONS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING APPLICATIONS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIGITAL PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIGITAL PLATFORMS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIGITAL PLATFORMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONSITE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONSITE SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONSITE SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE SERVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE SERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONCOLOGY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONCOLOGY DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ONCOLOGY DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPOINTMENT SCHEDULING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPOINTMENT SCHEDULING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPOINTMENT SCHEDULING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY BILLING MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY BILLING MANAGEMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY BILLING MANAGEMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COMPLIANCE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COMPLIANCE MANAGEMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COMPLIANCE MANAGEMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RECORD MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RECORD MANAGEMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RECORD MANAGEMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL TESTING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLINICAL TESTING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATHOLOGY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATHOLOGY DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATHOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIOLOGY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIOLOGY DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ICU MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ICU MONITORING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ICU MONITORING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY VITAL SIGN MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY VITAL SIGN MONITORING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY VITAL SIGN MONITORING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG THERAPY OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG THERAPY OPTIMIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DRUG THERAPY OPTIMIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIATION THERAPY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY RADIATION THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 139. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 140. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTIC SURGERY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ROBOTIC SURGERY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 142. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 143. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 147. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HYBRID, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 150. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 154. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 155. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 157. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HOSPITALS & HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 160. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HOSPITALS & HEALTHCARE PROVIDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HOSPITALS & HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 163. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 164. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 165. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 166. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 167. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 169. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 171. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 173. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 175. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 176. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 177. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 178. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 179. AMERICAS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 181. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 183. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 185. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 187. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 189. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 191. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 192. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 193. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 195. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 197. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 199. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 201. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 203. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 204. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 205. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 206. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 207. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 237. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 239. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 241. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 243. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 245. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 246. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 247. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 248. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 249. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 251. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 253. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 254. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 255. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 257. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 259. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 260. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 261. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 262. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 263. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 268. ASIA-PAC